Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding UnitedHealth Group’s layered insurance premiums, Optum analytics, and shifting medical cost ratios across hundreds of pages can drain even seasoned analysts. Need UnitedHealth Group insider trading Form 4 transactions before policy changes hit the headlines, or a quick view of the UnitedHealth Group quarterly earnings report 10-Q filing without combing through EDGAR? Stock Titan eliminates the paperwork burden.
Our AI engine reads every disclosure the moment it posts, turning dense text into plain English highlights. You’ll see UnitedHealth Group Form 4 insider transactions real-time, get UnitedHealth Group SEC filings explained simply, and access understanding UnitedHealth Group SEC documents with AI cards that surface what drives margin shifts, membership growth, and Optum revenue. Whether you’re tracking an UnitedHealth Group 8-K material events explained alert or comparing Rx benefit trends across quarters, the platform keeps all angles covered.
Investors rely on these insights to spot reimbursement risks, follow capital deployment, and gauge management incentives. The site connects each filing type to questions you actually ask:
- UnitedHealth Group annual report 10-K simplified � risk factors, medical cost ratio trends, Optum profitability.
- UnitedHealth Group earnings report filing analysis � quarter-over-quarter membership shifts and cash flow.
- UnitedHealth Group proxy statement executive compensation � incentive structures tied to quality outcomes.
With real-time updates, expert tagging, and AI-powered summaries, Stock Titan turns every disclosure into actionable clarity—so you can move from reading to decision-making faster.
UnitedHealth Group (UNH) filed an 8-K disclosing that the U.S. Department of Justice has opened formal criminal and civil inquiries into certain aspects of the company’s Medicare and Medicare Advantage activities. UNH says it proactively contacted the DOJ after media reports surfaced and is now supplying requested information.
The company emphasizes:
- Independent CMS audits have found its risk-adjustment coding practices "among the most accurate in the industry."
- A decade-long civil case on Medicare Advantage practices ended with a court-appointed Special Master finding no evidence of wrongdoing.
- UNH has launched third-party reviews of risk-assessment coding, managed-care practices and pharmacy services to enhance transparency.
Management states full confidence in existing compliance controls but cautions that investigation outcomes are unpredictable and could materially differ from current expectations, as noted in the forward-looking-statement disclaimer.
UnitedHealth Group (UNH) � Form 4 insider transaction.
CEO and Director Stephen J. Hemsley reported the acquisition of 198 deferred stock units on 07/01/2025 as part of his regular quarterly board compensation. These units are immediately vested but must be held until he leaves the Board, and the filing shows $0 purchase price (non-cash grant).
Following the award, Hemsley’s beneficial ownership stands at:
- 374,605.942 shares held directly
- 349.7176 shares held through the company 401(k)
- 735,115 shares held via family trusts
No derivative securities were reported, and there were no sales or open-market purchases. The filing appears to be routine compensation-related and does not indicate any change in strategic outlook or financial performance for UnitedHealth Group.
Form 4 filing for UnitedHealth Group (UNH) dated 07/02/2025 discloses routine quarterly equity compensation to non-employee director Paul R. Garcia.
- Transactions (07/01/2025): 173 deferred stock units (immediately vested, must be held until board service ends) and 96 shares of common stock, both awarded at $0 cost.
- Post-transaction ownership: 2,750 common shares held directly; 2,146 shares in a revocable trust; 45 and 55 shares in two additional trusts, for a total indirect holding of 2,246 shares.
- No derivative securities were acquired or disposed of; the filing cites the awards as regular quarterly director compensation, not incentive-based or market purchases.
The filing is administrative in nature, with no impact on company operations, capital structure, or insider sentiment beyond customary board compensation.
Form 4 filing for UnitedHealth Group (UNH) dated 07/02/2025 discloses routine quarterly equity compensation to non-employee director Paul R. Garcia.
- Transactions (07/01/2025): 173 deferred stock units (immediately vested, must be held until board service ends) and 96 shares of common stock, both awarded at $0 cost.
- Post-transaction ownership: 2,750 common shares held directly; 2,146 shares in a revocable trust; 45 and 55 shares in two additional trusts, for a total indirect holding of 2,246 shares.
- No derivative securities were acquired or disposed of; the filing cites the awards as regular quarterly director compensation, not incentive-based or market purchases.
The filing is administrative in nature, with no impact on company operations, capital structure, or insider sentiment beyond customary board compensation.
Form 4 filing for UnitedHealth Group (UNH) dated 07/02/2025 discloses routine quarterly equity compensation to non-employee director Paul R. Garcia.
- Transactions (07/01/2025): 173 deferred stock units (immediately vested, must be held until board service ends) and 96 shares of common stock, both awarded at $0 cost.
- Post-transaction ownership: 2,750 common shares held directly; 2,146 shares in a revocable trust; 45 and 55 shares in two additional trusts, for a total indirect holding of 2,246 shares.
- No derivative securities were acquired or disposed of; the filing cites the awards as regular quarterly director compensation, not incentive-based or market purchases.
The filing is administrative in nature, with no impact on company operations, capital structure, or insider sentiment beyond customary board compensation.
Form 4 filing for UnitedHealth Group (UNH) dated 07/02/2025 discloses routine quarterly equity compensation to non-employee director Paul R. Garcia.
- Transactions (07/01/2025): 173 deferred stock units (immediately vested, must be held until board service ends) and 96 shares of common stock, both awarded at $0 cost.
- Post-transaction ownership: 2,750 common shares held directly; 2,146 shares in a revocable trust; 45 and 55 shares in two additional trusts, for a total indirect holding of 2,246 shares.
- No derivative securities were acquired or disposed of; the filing cites the awards as regular quarterly director compensation, not incentive-based or market purchases.
The filing is administrative in nature, with no impact on company operations, capital structure, or insider sentiment beyond customary board compensation.
Form 4 filing for UnitedHealth Group (UNH) dated 07/02/2025 discloses routine quarterly equity compensation to non-employee director Paul R. Garcia.
- Transactions (07/01/2025): 173 deferred stock units (immediately vested, must be held until board service ends) and 96 shares of common stock, both awarded at $0 cost.
- Post-transaction ownership: 2,750 common shares held directly; 2,146 shares in a revocable trust; 45 and 55 shares in two additional trusts, for a total indirect holding of 2,246 shares.
- No derivative securities were acquired or disposed of; the filing cites the awards as regular quarterly director compensation, not incentive-based or market purchases.
The filing is administrative in nature, with no impact on company operations, capital structure, or insider sentiment beyond customary board compensation.
Upstart Holdings, Inc. (UPST) � Form 144 insider notice
Insider Natalia Mirgorodskaya has filed to sell up to 6,533 common shares through Charles Schwab on or about 07/02/2025. At the reference price used in the filing, the transaction is valued at roughly $457,674. The shares were obtained the same day via an employee stock-option cashless exercise. Mirgorodskaya also disclosed two prior sales in the last three months�764 shares for $35,874 on 05/20/2025 and 1,340 shares for $59,215 on 05/23/2025.
With 95,144,858 shares outstanding, the proposed sale represents approximately 0.007 % of total shares, indicating a limited potential impact on the float. The filer certified that no undisclosed adverse information is known, in accordance with Rule 144 requirements.
Upstart Holdings, Inc. (UPST) � Form 144 insider notice
Insider Natalia Mirgorodskaya has filed to sell up to 6,533 common shares through Charles Schwab on or about 07/02/2025. At the reference price used in the filing, the transaction is valued at roughly $457,674. The shares were obtained the same day via an employee stock-option cashless exercise. Mirgorodskaya also disclosed two prior sales in the last three months�764 shares for $35,874 on 05/20/2025 and 1,340 shares for $59,215 on 05/23/2025.
With 95,144,858 shares outstanding, the proposed sale represents approximately 0.007 % of total shares, indicating a limited potential impact on the float. The filer certified that no undisclosed adverse information is known, in accordance with Rule 144 requirements.
Upstart Holdings, Inc. (UPST) � Form 144 insider notice
Insider Natalia Mirgorodskaya has filed to sell up to 6,533 common shares through Charles Schwab on or about 07/02/2025. At the reference price used in the filing, the transaction is valued at roughly $457,674. The shares were obtained the same day via an employee stock-option cashless exercise. Mirgorodskaya also disclosed two prior sales in the last three months�764 shares for $35,874 on 05/20/2025 and 1,340 shares for $59,215 on 05/23/2025.
With 95,144,858 shares outstanding, the proposed sale represents approximately 0.007 % of total shares, indicating a limited potential impact on the float. The filer certified that no undisclosed adverse information is known, in accordance with Rule 144 requirements.
FAQ
What is the current stock price of Unitedhealth Gp (UNH)?
What is the market cap of Unitedhealth Gp (UNH)?
What is UnitedHealth Group's core business?
How does UnitedHealth Group generate revenue?
What role does its Optum division play?
How does UnitedHealth Group maintain operational efficiency?
What distinguishes UnitedHealth Group from its competitors?
Who are the primary beneficiaries of its services?
What key challenges does UnitedHealth Group navigate?
How is technological innovation integrated into its operations?
